Litcius/Paper detail

Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis

Sarah Dewilde, Alison Griffiths, Cynthia Z. Qi, Glenn Phillips, Deborah Gelinas, Edward Brauer, Renato Mantegazza, James F. Howard

2024Journal of the Neurological Sciences17 citationsDOIOpen Access PDF

Topics & Concepts

Myasthenia gravisPost hocPost-hoc analysisMedicineAggregate (composite)Physical medicine and rehabilitationPsychologyInternal medicineMaterials scienceNanotechnologyMyasthenia Gravis and ThymomaAdrenal Hormones and DisordersPeripheral Neuropathies and Disorders
Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis | Litcius